Skip to main content
SpringerLink
Log in

Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The incidence of brain metastasis from hepatocellular carcinoma (HCC) is increasing because of the improved survival outcome of HCC patients, but the prognosis of these patients is extremely poor. HCC patients with brain metastasis were investigated to identify their prognostic factors for overall survival. Patients with brain metastasis from HCC who had been treated with whole-brain radiotherapy (WBRT) in five hospitals were enrolled in the study. The medical records of the patients were reviewed, and the clinical factors were analyzed to identify the prognostic factors for overall survival. Of the total of 97 patients who were enrolled in the study, 83 were male and the median age at the brain metastases was 56.6 years. Motor weakness (43.3 %) and headache (41.2 %) were common presenting symptoms. The median AFP level was 4180 ng/ml, and 81 patients were assessed as belonging to Child-Pugh classification A upon the diagnosis of brain metastasis. WBRT alone in 71 patients, surgery or radiosurgery combined with WBRT as the adjuvant setting in 18 patients, and WBRT as salvage treatment in 8 patients were performed. The median overall survival of the patients was 3.5 months. In the multivariate analysis, the ECOG performance status (PS), Child-Pugh classification, AFP, and treatment aim showed significant association with the overall survival of the patients. Based on these factors, a nomogram predicting the prognosis was developed. The concordance index of the nomogram was 0.74, and the prediction was well calibrated. In conclusion, the survival outcome of patients with brain metastasis from HCC can be predicted with the nomogram constructed from the ECOG PS, Child-Pugh classification, AFP, and treatment aim.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kim M, Na DL, Park SH, Jeon BS, Roh JK (1998) Nervous system involvement by metastatic hepatocellular carcinoma. J Neurooncol 36:85–90

    Article  CAS  PubMed  Google Scholar 

  2. Chang L, Chen YL, Kao MC (2004) Intracranial metastasis of hepatocellular carcinoma: review of 45 cases. Surg Neurol 62:172–177. doi:10.1016/j.surneu.2003.10.002

    Article  PubMed  Google Scholar 

  3. Murakami K, Nawano S, Moriyama N, Sekiguchi R, Satake M, Fujimoto H, Ichikawa T (1996) Intracranial metastases of hepatocellular carcinoma: CT and MRI. Neuroradiology 38(Suppl 1):S31–S35

    Article  PubMed  Google Scholar 

  4. Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH, Kim JH, Yoo NC (2009) Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neurooncol 91:307–313. doi:10.1007/s11060-008-9713-3

    Article  PubMed  Google Scholar 

  5. Shao YY, Lu LC, Cheng AL, Hsu CH (2011) Increasing incidence of brain metastasis in patients with advanced hepatocellular carcinoma in the era of antiangiogenic targeted therapy. Oncologist 16:82–86. doi:10.1634/theoncologist.2010-0272

    Article  PubMed Central  PubMed  Google Scholar 

  6. Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B, Van Houtte P, Brotchi J, Levivier M (2004) Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60:218–224. doi:10.1016/j.ijrobp.2004.02.017

    Article  PubMed  Google Scholar 

  7. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751

    Article  CAS  PubMed  Google Scholar 

  8. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, de Oliveira Borges SR, Wajsbrot DB (2000) Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46:1155–1161

    Article  CAS  PubMed  Google Scholar 

  9. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514. doi:10.1016/j.ijrobp.2007.06.074

    Article  PubMed  Google Scholar 

  10. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500. doi:10.1056/NEJM199002223220802

    Article  CAS  PubMed  Google Scholar 

  11. Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ (2003) Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 61:73–80

    Article  PubMed  Google Scholar 

  12. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672. doi:10.1016/S0140-6736(04)16250-8

    Article  PubMed  Google Scholar 

  13. Park TY, Na YC, Lee WH, Kim JH, Chang WS, Jung HH, Chang JH, Chang JW, Park YG (2013) Treatment options of metastatic brain tumors from hepatocellular carcinoma: surgical resection vs. gamma knife radiosurgery vs. whole brain radiation therapy. Brain Tumor Res Treat 1:78–84. doi:10.14791/btrt.2013.1.2.78

    Article  PubMed Central  PubMed  Google Scholar 

  14. Jiang XB, Ke C, Zhang GH, Zhang XH, Sai K, Chen ZP, Mou YG (2012) Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer 12:49. doi:10.1186/1471-2407-12-49

    Article  PubMed Central  PubMed  Google Scholar 

  15. Han MS, Moon KS, Lee KH, Cho SB, Lim SH, Jang WY, Jung TY, Kim IY, Jung S (2013) Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor. BMC Cancer 13:567. doi:10.1186/1471-2407-13-567

    Article  PubMed Central  PubMed  Google Scholar 

  16. Lim S, Lee S, Lim JY, Park JS, Seong JS, Chang WS, Han KH, Choi HJ (2014) Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma. J Neurooncol 120:199–207. doi:10.1007/s11060-014-1546-7

    Article  CAS  PubMed  Google Scholar 

  17. Kim KS, Kim K, Chie EK, Kim YJ, Yoon JH, Lee H-S, Ha SW (2014) Prognostic stratification of brain metastases from hepatocellular carcinoma. J Neurooncol 120:209–214

    Article  PubMed  Google Scholar 

  18. Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA, Sperduto PW, Mehta MP, Machtay M, Kattan MW (2012) A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro-oncology 14:910–918. doi:10.1093/neuonc/nos087

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Radiation Oncology, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea

      Younghee Park, Tae Ryool Koo & Ah Ram Chang

    2. Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea

      Younghee Park, Kyung Su Kim, Kyubo Kim, Eui Kyu Chie & Jin Ho Kim

    3. Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea

      Jae-Sung Kim

    4. Center for Proton Therapy, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea

      Tae Hyun Kim & Dae Yong Kim

    5. Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea

      Won Il Jang & Mi-Sook Kim

    Authors
    1. Younghee Park
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Kyung Su Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Kyubo Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Eui Kyu Chie
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Jin Ho Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Jae-Sung Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Tae Hyun Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Dae Yong Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Won Il Jang
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Mi-Sook Kim
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Tae Ryool Koo
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Ah Ram Chang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Kyubo Kim.

    Ethics declarations

    Conflict of interest

    None.

    Additional information

    Younghee Park and Kyung Su Kim have equally contributed to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Park, Y., Kim, K.S., Kim, K. et al. Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study. J Neurooncol 125, 377–383 (2015). https://doi.org/10.1007/s11060-015-1926-7

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s11060-015-1926-7

    Keywords

    Search

    Navigation